WO2006062909A3 - Methods and compositions for enhancing vascular access - Google Patents
Methods and compositions for enhancing vascular access Download PDFInfo
- Publication number
- WO2006062909A3 WO2006062909A3 PCT/US2005/043967 US2005043967W WO2006062909A3 WO 2006062909 A3 WO2006062909 A3 WO 2006062909A3 US 2005043967 W US2005043967 W US 2005043967W WO 2006062909 A3 WO2006062909 A3 WO 2006062909A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- implantable material
- cells
- methods
- present
- functional
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
Abstract
Priority Applications (43)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200580042372XA CN101076360B (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
EP05848586A EP1824526B1 (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
DE602005022481T DE602005022481D1 (en) | 2004-12-08 | 2005-12-06 | COMPOSITIONS AND THEIR USE FOR BETTER VESSEL ACCESS |
CN2005800421993A CN101141988B (en) | 2004-12-08 | 2005-12-06 | Materials and methods for treating and managing plaque disease |
PCT/US2005/043844 WO2006062871A2 (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
CA2589597A CA2589597C (en) | 2004-12-08 | 2005-12-06 | Methods and compositions for enhancing vascular access |
US11/792,350 US20080119946A1 (en) | 2004-12-08 | 2005-12-06 | Methods And Compositions For Enhacing Vascular Access |
AU2005314263A AU2005314263B2 (en) | 2004-12-08 | 2005-12-06 | Methods and compositions for enhancing vascular access |
JP2007545545A JP2008522735A (en) | 2004-12-08 | 2005-12-06 | Methods and compositions for enhancing vascular access |
JP2007545539A JP5674256B2 (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally invasive administration of cell-containing flowable compositions |
AU2005314312A AU2005314312B2 (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
AT05853004T ATE474608T1 (en) | 2004-12-08 | 2005-12-06 | COMPOSITIONS AND THEIR USE FOR BETTER VASCULAR ACCESS |
CA2589588A CA2589588C (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
CN201210448869.3A CN103055350B (en) | 2004-12-08 | 2005-12-06 | Materials and methods for minimally-invasive administration of cell-containing flowable composition |
EP05853004A EP1824529B1 (en) | 2004-12-08 | 2005-12-06 | Compositions and their use for enhancing vascular access |
CA 2612751 CA2612751A1 (en) | 2005-06-21 | 2006-06-05 | Vegf-containing transport media composition for storing cells engrafted in a biocompatible matrix |
AU2006262682A AU2006262682B2 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
JP2008518189A JP5632580B2 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for improving vascular access |
CN201210246619.1A CN102743792B (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
EP20060772165 EP1901680B1 (en) | 2005-06-21 | 2006-06-05 | Crypreservation of biocompatible material |
SG201002482-6A SG161258A1 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
SG2013075387A SG195537A1 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
PCT/US2006/021755 WO2007001744A2 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
ES06772165.4T ES2541684T3 (en) | 2005-06-21 | 2006-06-05 | Cryopreservation of biocompatible material |
CA 2818182 CA2818182C (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
US11/922,729 US20090035346A1 (en) | 2005-06-21 | 2006-06-05 | Methods and Compositions for Enhancing Vascular Access |
CN2010102362140A CN101878757A (en) | 2005-06-21 | 2006-06-05 | Be used to strengthen the method and composition of vascular access |
CN2006800279776A CN101257861B (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
IL183786A IL183786A (en) | 2004-12-08 | 2007-06-07 | Methods and compositions for enhancing vascular access |
IL183784A IL183784A (en) | 2004-12-08 | 2007-06-07 | Materials for minimally-invasive administration of a cell-containing flowable composition |
IL188263A IL188263A (en) | 2005-06-21 | 2007-12-19 | Transport media compositions for storing an implantable material and methods for storing an implantable material |
HK08101925.0A HK1112429A1 (en) | 2004-12-08 | 2008-02-21 | Compositions and their use for enhancing vascular access |
US12/626,823 US20100204783A1 (en) | 2005-12-06 | 2009-11-27 | Methods and compositions for enhancing vascular access |
US12/779,223 US20100318016A1 (en) | 2004-12-08 | 2010-05-13 | Methods and Compositions for Enhancing Vascular Access |
IL209574A IL209574A (en) | 2004-12-08 | 2010-11-25 | Materials for minimally-invasive administration of a cell-containing flowable composition |
AU2010249280A AU2010249280B2 (en) | 2004-12-08 | 2010-12-10 | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
US13/040,650 US20110229549A1 (en) | 2004-12-08 | 2011-03-04 | Methods and Compositions for Enhancing Vascular Access |
IL212764A IL212764A0 (en) | 2004-12-08 | 2011-05-08 | Methods and compositions for enhancing vascular access |
JP2012110766A JP2012148164A (en) | 2004-12-08 | 2012-05-14 | Material and method for minimally-invasive administration of cell-containing flowable composition |
JP2012133043A JP2012166084A (en) | 2005-06-21 | 2012-06-12 | Method and composition for enhancing vascular access |
IL220806A IL220806A (en) | 2005-06-21 | 2012-07-05 | Method and compositions for enhancing vascular access |
JP2012256581A JP2013039431A (en) | 2004-12-08 | 2012-11-22 | Material and method for minimally-invasive administration of cell-containing flowable composition |
JP2014239567A JP2015042682A (en) | 2004-12-08 | 2014-11-27 | Material and method for minimally-invasive administration of cell-containing flowable composition |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63415504P | 2004-12-08 | 2004-12-08 | |
US60/634,155 | 2004-12-08 | ||
US66385905P | 2005-03-21 | 2005-03-21 | |
US60/663,859 | 2005-03-21 | ||
US68205405P | 2005-05-18 | 2005-05-18 | |
US60/682,054 | 2005-05-18 | ||
US4984405P | 2005-12-06 | 2005-12-06 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/922,729 Continuation US20090035346A1 (en) | 2005-06-21 | 2006-06-05 | Methods and Compositions for Enhancing Vascular Access |
PCT/US2006/021755 Continuation WO2007001744A2 (en) | 2005-06-21 | 2006-06-05 | Methods and compositions for enhancing vascular access |
US12/626,823 Continuation-In-Part US20100204783A1 (en) | 2005-12-06 | 2009-11-27 | Methods and compositions for enhancing vascular access |
US12/779,223 Continuation US20100318016A1 (en) | 2004-12-08 | 2010-05-13 | Methods and Compositions for Enhancing Vascular Access |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006062909A2 WO2006062909A2 (en) | 2006-06-15 |
WO2006062909A3 true WO2006062909A3 (en) | 2006-08-31 |
Family
ID=36570653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/043967 WO2006062909A2 (en) | 2004-12-08 | 2005-12-06 | Methods and compositions for enhancing vascular access |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006062909A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006238892B2 (en) | 2005-04-21 | 2011-01-27 | Massachusetts Institute Of Technology | Materials and methods for altering an immune response to exogenous and endogenous immunogens, including syngeneic and non-syngeneic cells, tissues or organs |
JP5632580B2 (en) * | 2005-06-21 | 2014-11-26 | シャイア リジェネラティブ メディシン, インコーポレイテッド | Methods and compositions for improving vascular access |
US20100092532A1 (en) * | 2006-11-07 | 2010-04-15 | Helen Marie Nugent | Materials and Methods for Treating and Managing Angiogenesis-Mediated Diseases |
WO2008057590A2 (en) * | 2006-11-07 | 2008-05-15 | Pervasis Therapeutics, Inc. | Methods and compositions for modulating tissue modeling |
JP6356065B2 (en) | 2011-08-01 | 2018-07-11 | ラミネート・メディカル・テクノロジーズ・リミテッド | External vascular support |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820626A (en) * | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
WO2001062241A1 (en) * | 2000-02-23 | 2001-08-30 | Smithkline Beecham Corporation | Method for the prevention or reduction of vascular access dysfunction |
US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
US20020077694A1 (en) * | 1999-06-30 | 2002-06-20 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
WO2002062335A2 (en) * | 2001-01-16 | 2002-08-15 | Vascular Therapies, Llc | Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
WO2004002549A1 (en) * | 2002-06-28 | 2004-01-08 | Novartis Ag | Use of organic compounds |
-
2005
- 2005-12-06 WO PCT/US2005/043967 patent/WO2006062909A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4820626A (en) * | 1985-06-06 | 1989-04-11 | Thomas Jefferson University | Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself |
US6328762B1 (en) * | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
US20020077694A1 (en) * | 1999-06-30 | 2002-06-20 | Pharmasonics, Inc. | Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts |
WO2001062241A1 (en) * | 2000-02-23 | 2001-08-30 | Smithkline Beecham Corporation | Method for the prevention or reduction of vascular access dysfunction |
WO2002062335A2 (en) * | 2001-01-16 | 2002-08-15 | Vascular Therapies, Llc | Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
WO2004002549A1 (en) * | 2002-06-28 | 2004-01-08 | Novartis Ag | Use of organic compounds |
Non-Patent Citations (2)
Title |
---|
HAZINEDAROGLU S M ET AL: "Immediate postimplant hemodialysis through a new ''self-sealing'' heparin-bonded polycarbonate/urethane graft", TRANSPLANTATION PROCEEDINGS, ORLANDO, FL, US, vol. 36, no. 9, November 2004 (2004-11-01), pages 2599 - 2602, XP004697046, ISSN: 0041-1345 * |
HIRIGOYEN M B ET AL: "Periadventitial delivery of heparin in the prevention of microvenous thrombosis", JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, SAUNDERS, PHILADELPHIA, PA, US, vol. 54, no. 9, September 1996 (1996-09-01), pages 1097 - 1102, XP001097380, ISSN: 0278-2391 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006062909A2 (en) | 2006-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL212764A0 (en) | Methods and compositions for enhancing vascular access | |
WO2007001744A3 (en) | Methods and compositions for enhancing vascular access | |
Yao et al. | Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity | |
WO2008019127A3 (en) | Solid dressing for treating wounded tissue | |
EP1795213A3 (en) | Implantable microbial cellulose materials for various medical applications | |
WO2007035843A3 (en) | Methods and compositions for organ and tissue functionality | |
WO2006062909A3 (en) | Methods and compositions for enhancing vascular access | |
Morris et al. | Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds | |
WO2006026325A3 (en) | Implantable tissue compositions and method | |
WO2004101758A3 (en) | Composition for maintaining organ and cell viability | |
JP2009525795A (en) | Medical adhesives and hemostats | |
WO2006047841A3 (en) | Engineering with homing factors | |
WO2004076631A3 (en) | Biologically active native biomatrix composition | |
EP2418271A3 (en) | Methods and compositions for treatment of bone defects with placental cell populations | |
WO2006093857A3 (en) | Method of providing readily available cellular material derived from peripheral blood and a composition thereof | |
WO2008134610A8 (en) | Growth factor modified extracellular matrix material and methods for preparation and use thereof | |
US10092602B2 (en) | Elastic tissue matrix derived hydrogel | |
AU2003257319A1 (en) | Biocompatible porous ti-ni material | |
WO2005012492A8 (en) | Human skin equivalents expressing exogenous polypeptides | |
WO2003099230A3 (en) | Electroprocessed collagen and tissue engineering | |
ATE411057T1 (en) | CERAMIC-BASED INJECTABLE IMPLANTS FOR FILLING SOFT TISSUE | |
EP2198895A3 (en) | Porous structures of microbial-derived cellulose for in vivo implantation | |
WO2010047587A3 (en) | Implant for prostheses | |
WO2005058243A3 (en) | Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a | |
Sharma et al. | Albumin removal from human fibrinogen preparations for manufacturing human fibrin-based biomaterials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200580042199.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WPC | Withdrawal of priority claims after completion of the technical preparations for international publication |
Ref document number: US Free format text: WITHDRAWN AFTER TECHNICAL PREPARATION FINISHED |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2589597 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11792350 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005853004 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007545545 Country of ref document: JP Ref document number: 183784 Country of ref document: IL Ref document number: 183786 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005314263 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2362/KOLNP/2007 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2005314263 Country of ref document: AU Date of ref document: 20051206 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005314263 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005853004 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 212764 Country of ref document: IL |